The Use of Humanized Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Infection

The Use of Humanized Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Infection

Monoclonal antibodies are widely used both in infants and in adults for several indications. Humanized monoclonal antibodies (palivizumab) have been used for many years for the prevention of respiratory syncytial virus infection in pediatric populations (preterm infants, infants with chronic lung di...

Full description

Saved in:
Bibliographic Details
Main Authors: Marcello Lanari, Silvia Vandini, Santo Arcuri, Silvia Galletti, Giacomo Faldella
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2013/359683
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items